{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18"}],"title":"Better"},{"measurements":[{"groupId":"OG000","value":"21"}],"title":"No Change"},{"measurements":[{"groupId":"OG000","value":"20"}],"title":"Worse"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"}],"units":"Participants"}],"description":"A self-reported scale that measures the severity of pain based on the average pain experienced over the past 24 hours. The severity scores range from 0 (no pain) to 10 (pain as severe as you can imagine).","groups":[{"description":"200 mg abemaciclib given orally once every 12 hours for 28 days (1 cycle). Participants may continue to receive treatment until discontinuation criteria are met.","id":"OG000","title":"Abemaciclib"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All randomized participants with a baseline and at least 1 post-baseline mBPI-sf data.","reportingStatus":"POSTED","timeFrame":"Cycle 6 Day 1","title":"Number of Participants With Categorical Change From Baseline in Brief Pain Inventory Short Form (mBPI-sf) - Worst Pain Score","type":"SECONDARY","unitOfMeasure":"Participants"}